Evommune EVMN Reclass Common Stock Issued For Legal Services To Deferred Offering Costsin Dollars
Reclass Common Stock Issued For Legal Services To Deferred Offering Costsin Dollars at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:ReclassCommonStockIssuedForLegalServicesToDeferredOfferingCostsinDollars.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's reclass common stock issued for legal services to deferred offering costsin dollars.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's reclass common stock issued for legal services to deferred offering costsin dollars?
- Evommune (EVMN) reported reclass common stock issued for legal services to deferred offering costsin dollars of -$63K in Q4 2025.
- What does reclass common stock issued for legal services to deferred offering costsin dollars mean?
- The dollar value of common stock issued to settle obligations for legal services, which is subsequently reclassified as a deferred offering cost. This metric identifies non-cash expenses that are capitalized rather than immediately expensed. It provides insight into how the company manages professional service costs during capital-intensive phases like IPOs or private placements.